Virpax Pharmaceuticals, Inc. (VRPX) Revenue History
Annual and quarterly revenue from 2018 to present
VRPX Revenue Over Time (2018–2024)
VRPX Revenue Growth History
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
| Q1 2024 | $0 | — |
| Q4 2023 | $0 | — |
| Q3 2023 | $0 | — |
| Q2 2023 | $0 | — |
| Q1 2023 | $0 | — |
VRPX Revenue Analysis (2018–2024)
Current Revenue & Growth
As of May 30, 2026, Virpax Pharmaceuticals, Inc. (VRPX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2024) recorded $0 in revenue
Historical Growth Trajectory
VRPX's historical revenue data shows various trends over time.
Peer Comparison
Compared to Healthcare sector peers — including NKTR (-36.2% YoY), PCRX (+4.6% YoY), and ABBV (+8.6% YoY). Compare VRPX vs NKTR →
VRPX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 VRPXCurrent | $0 | - | - | - | |
 NKTR | $55M | -36.2% | -18.4% | -236.8% | |
 PCRX | $726M | +4.6% | +11.1% | 4.6% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 PFE | $62.6B | +1.4% | +8.5% | 24.7% |
VRPX Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-12,079,935 | - |
| 2023 | $0 | - | $0 | - | $-15,689,788 | - |
| 2022 | $0 | - | $0 | - | $-21,845,133 | - |
| 2021 | $0 | - | $0 | - | $-12,025,500 | - |
| 2020 | $0 | - | $0 | - | $-4,195,719 | - |
| 2019 | $0 | - | $0 | - | $-3,181,868 | - |
| 2018 | $0 | - | $0 | - | $-2,625,962 | - |
What if you invested $1,000 in VRPX back in 2018?
Total return with dividends reinvested · 8+ years of data
Calculate ReturnsHow much would $100/month in VRPX be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs VRPX Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationVRPX vs DBVT — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs DBV Technologies S.A..
Compare NowVRPX — Frequently Asked Questions
Quick answers to the most common questions about buying VRPX stock.
Is VRPX's revenue growth accelerating or slowing?
VRPX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is VRPX's revenue history from 2018 to 2026?
Virpax Pharmaceuticals, Inc. (VRPX) revenue history spans 2018 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is VRPX's long-term revenue growth rate (CAGR)?
Virpax Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for VRPX.
Why does VRPX's quarterly revenue fluctuate?
VRPX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Virpax Pharmaceuticals, Inc.'s revenue data from 2018 to 2026 shows full historical quarterly detail on this page.
How is VRPX's revenue distributed by segment?
VRPX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does VRPX's revenue compare to industry peers?
Virpax Pharmaceuticals, Inc. (VRPX) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.